Purpose: The purpose of the study was to evaluate the incidence and causes of registered blindness and low vision in Eastern Bulgaria.
Methods: Documentation per each included patient based on archives of the Expert Disability committee was evaluated and divided in two intervals. The cumulative incidence per 100 000 was calculated in 3 severity groups for bilateral and monocular blindness and by residence.
Results: The incidence of binocular blindness decreased from 63.79 to 41.61 for males and from 64.21 to 41.14 for females during the second period. Meanwhile, monocular blindness increased from 41.14 to 65.14 for males and from 33.01 to 48.83 for females. It rapidly increases after 60 years of age and is the highest for those over 80. Patients with visual acuity (VA) below 0.05 comprise 40-35%, between 0.06 and 0.1 - 22- 35%, and 0.15 to 0.3 - 38-34%. The proportion and incidence of patients with VA below 0.05 have decreased two times during the second period among residents of cities and remained high - 42-48% in the rural population. Severe monocular blindness was significantly higher among males across the whole population. In the age group below 19 years, the leading causes of binocular blindness were retinopathy of prematurity (ROP), congenital glaucoma, microphthalmos and congenital cataract and for monocular impairment - trauma and amblyopia. For those above 20, the main causes were glaucoma, end-stage diabetic retinopathy, cataract - both with significant reduction in the incidence, AMD and trauma.
Conclusions: Systematic evaluation of the deteriorated quality of life and estimation of the cost of vision loss and eye diseases to individuals and their families as well as extended family caregivers and thirdparty payers, the health care system and Bulgarian society is essential in the development of evidence-based interventions that translate research into enhanced clinical and community practice and prevention of unnecessary visual impairment.
Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol, 2012;96:614-8.
Bloch SB, Larsen M, Munch IC. Incidence of legal blindness from age-related macular degeneration in Denmark: Year 2000 to 2010. Am J Ophthalmol, 2012;153:209-213.
Skaat A, Chetrit A, Belkin M, Kinori M, Kalter- Leibovici O. Time trends in the incidence and causes of blindness in Israel. Am J Ophthalmol, 2012;153:214-221.
Zambelli-Weinr A, Crews JE, Friedman DS. Disparities in adult vision care in the United States. Am J Ophthalmol, 2012;154:S23-S30.
Stevens GA, White RA, Flaxman SR, Price H, Jonas JB, Keeffe J, Leashe J, Naidoo K, Pesudovs K, Resnikoff S, Taylor H, Bourne RRA et al. Global prevalence of vision impairment and blindness. Magnitude and temporal trends, 1990-2010. Ophthalmology, 2013 Dec;120(12):2377-84.
International Statistical Classification of Diseases and Related Health Problems 10th Revision, Available at: .
Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age standardization of rates: a new WHO standard, GPE Discussion Paper Series: No.31 EIP/GPE/EBD World Health Organization 2001 Available at:
Crewe JM, Morgan WH, Morlet N, Spilsbury K, Mukhtar A, Clark A, Ng JQ, Crowley M, Semmens JB. Assessing the diagnostic validity of a blind register. Clin Experiment Ophthalmol, 2011 Aug;39(6):494-500. doi: 10.1111/j.1442- 9071.2011.02509.x. Epub 2011 Mar 24.
Crewe J, Morgan WH, Morlet N, Clark A, Lam G, J. Prevalence of blindness in Western Australia: a population study using capture and recapture techniques Br J Ophthalmol, 2012 Apr;96(4):478-81. doi: 10.1136/bjophthalmol-2011-300908. Epub 2011 Nov 17.
Yong VK, Morgan WH, Cooper RL, Shaw M, Bremner AP, Bulsara M, Yu DY. Trends in registered blindness and its causes over 19 years in Western Australia. Ophthalmic Epidemiol, 2006 Feb;13(1):35-42.
Finger RP, Berndt B, Wolfram C, Holz F. Blindness and visual impairment in Germany. Dtsch Arztbl Int. 2012 July; 109(27-28):484-489.
Finger RP, Fimmers R, Holz FG, Scholl HP. Incidence of blindness and severe visual impairment in Germany: projections for 2030. Invest Ophthalmol Vis Sci. 2011 Jun 21;52(7):4381-9. Print 2011 Jun
Finger RP, Fimmers R, Holz FG, Scholl HP. Prevalence and causes of registered blindness in the largest federal state of Germany. Br J Ophthalmol, 2011 Aug;95(8):1061-7. Epub 2011 Mar 3.
Claessen H, Genz J, Bertram B, Trautner C, Giani G, Zöllner I, Icks A. Evidence for a considerable decrease in total and cause-specific incidences
of blindness in Germany. Eur J Epidemiol, 2012 Jul;27(7):519-24. doi: 10.1007/s10654-012-9705-7. Epub 2012 Jun 19.
Bunce C, Xing W, Wormald R. Causes of blind and partial sight certifications in England and Wales: April 2007-March 2008. Eye (Lond), 2010 Nov;24(11):1692-9. Epub 2010 Sep 17 16. Bunce C, Wormald R. Leading causes of certification for blindness and partial sight in England & Wales. BMC Public Health, 2006 Mar 8;6:58.
Barry RJ, PI Murray . Unregistered visual impairment : is registration a failing system? Br.J. Ophthalmol, 2005;89:995-998.
Malik AN, Bunce C, Wormald R, Suleman M, Stratton I, Gray JA. Geographical variation in certification rates of blindness and sight impairment in England, 2008-2009. BMJ Open, 2012 Nov 19;2(6):e001496. doi: 10.1136/bmjopen- 2012-001496. Print 2012.
Liew G, Michaelides M, Bunce C. A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010. BMJ Open, 2014 Feb 12;4(2):e004015. doi: 10.1136/ bmjopen-2013-004015.
Bodeu-Livinec F, Surman G, Kaminski M, Wilkinson AR, Ancel PY,Kurinczuk JJ Recent trends in visual impairment and blindness in the UK. Arch Dis Child, 2007 Dec;(12):1099-104.
Farber MD. National Registry for the Blind in Israel: estimation of prevalence and incidence rates and causes of blindness. Ophthalmic Epidemiol, 2003 Oct;10(4):267-77.
Avisar R, Friling R, Snir M, Avisar I, Weinberger D.Estimation of prevalence and incidence rates and causes of blindness in Israel, 1998-2003. Isr Med Assoc J, 2006 Dec;8(12):880-1.
Kelliher C, Kenny D, O`Brien C. Trends in blind registration in the adult population of the Republic of Ireland 1996-2003. Br J Ophthalmol, 2006 Mar;90(3):367-71.
Cruciani F, Amore F, Albanese G, Anzidei R. Investigation about causes of blindness and low vision among members of the Blind and Visually impaired Italian Union (UICI) Clin Ter 2011;162(2):e35-42.
Al-Merjan JI, Pandova MG, Al-Ghanim M, Al- Wayel A, Al-Mutairi S. Registered blindness and low vision in Kuwait. Ophthalmic Epidemiol, 2005 Aug;12(4):251-7.
Khandekar R, Al Harby S. National Register for the Blind: a tool for health programme management. East Mediterr Health J, 2006 Jan-Mar;12(1-2):170-7.
Gieser SC, Vassileva P. West SK Ophthalmology in Bulgaria. Arch Ophthalmol, 1994 May;112(5):687-90.
Malihi M, Filho ERM, Hodge DO, Sit AJ. Long- Term Trends in Glaucoma-Related Blindness in Olmsted County, Minnesota Ophthalmology 2013;121(1):134-141.
29. O`Colmain U, Anijeet D, Vosoughi M, Sinclair A, Sanders. R Glaucoma blind registration in Fife (2000-2009) a retrospective cohort. Ophthalmic Physiol Opt, 2011 Jul;31(4):360-6. doi: 10.1111/j.1475-1313.2011.00849.x. Epub 2011 May 26.
Prokofyeva E, Zrenner E. Epidemiology of major eye diseases leading to blindness in Europe: a literature review. Ophthalmic Res, 2012;47(4):171-88. doi: 10.1159/000329603. Epub 2011 Nov 26.
Centers for Disease Control and Prevention. [2013 (cited 2013 Jul 20)]. .
Hall HN, Chinn DJ, Sinclair A, Styles CJ. Epidemiology of blindness attributable to diabetes in Scotland: change over 20 years in a defined population Diabet Med, 2013 Nov;30(11):1349-54. doi: 10.1111/ dme.12223. Epub 2013 Jun 7.
Borisova AM, Kovacheva R, Shinkov A, Atanasova I, Aslanova N, Vlachov J, Dokovska L. A study of the influence of diabetes mellitus among not selected Bulgarian population like cross-sectional study. Endocrinology, 2007;12(1):42-49.
Donièová V, Brož J, Sorin I. Health care provision for people with diabetes and postgraduate training of diabetes specialists in eastern European countries. J Diabetes Sci Technol, 2011 Sep 1;5(5):1124-36.
Kong L, Fry M, Al-Sammaraie M, Gilbert C, Steinkuller PG .An update on progress and changing epidemiology of causes of childhood blindness worldwide. J AAPOS, 2012;16:501-507.
Solebo AL, Rahi J. Epidemiology, aetiology and management of visual impairment in children. Arch Dis Child, 2014 Apr;99(4):375-9.
Mitry D, Bunce C, Wormald R, Bowman R. Childhood visual impairment in England: a rising trend. Arch Dis Child, 2013 May;98(5):378-80. doi: 10.1136/archdischild-2012-301970. Epub 2012 Dec 6.
Fact List | RIDBC - Royal Institute for Deaf and Blind Children. Available at: .
Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control Early Hum Dev, 2008 Feb;84(2):77-82. doi: 10.1016/j.earlhumdev. 2007.11.009. Epub 2008 Jan 29.
Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res, 2013 Dec;74 Suppl 1:35-49. doi: 10.1038/pr.2013.205.